Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RxSpan MD vs Gala Health

RxSpan MD
Graded #10

Level

vs
Gala Health
Graded #8

Level

The verdict

Too close to call — both grade 86/100 (B).

RxSpan MD and Gala Health land on the same WeighScore, so neither clears the other on our six graded dimensions. Gala Health sits one line higher on the board (#8 vs #10) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGala Health +4
86
90
Dose & formulationRxSpan MD +6
89
83
Clinical oversightRxSpan MD +3
88
85
Labs & monitoringEven
83
83
FulfillmentRxSpan MD +1
89
88
Contract termsGala Health +1
85
86
RxSpan MD · left barGala Health · right bar

The numbers

MetricRxSpan MDGala Health
WeighScore86/10086/100
GradeBB
Scorecard rank#10#8
SemaglutideFrom $194/moNot disclosed
Tirzepatide$329/mo$179/mo
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjection only
RxSpan MD

Graded #10 · B

Strengths

  • Available in all 50 states
  • Transparent, all-inclusive published pricing — consult, medication, supplies, shipping and support, cancel anytime, from ~$194/mo compounded semaglutide on an annual plan
  • Both injectable and a real oral (capsule) route, plus compounded and an advertised brand-name lane
  • Physician-led by a named, board-certified founder (Dr. John Diaz) with 24/7 messaging and coaching

Where it loses points

  • Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
  • Published pricing is for the compounded line — brand-name pricing isn’t itemized
  • A prescription isn’t guaranteed — a provider reviews eligibility after checkout
Gala Health

Graded #8 · B

Strengths

  • Low compounded entry — tirzepatide $179/mo, microdose from $149, 3-month plans from $199
  • Available in all 50 states
  • Keeps a brand-name path open (Ozempic listed at $1,299)
  • HRT and menopause care available alongside GLP-1

Where it loses points

  • Compounded formulations are not FDA-approved
  • Brand-name Ozempic is priced steeply at $1,299
  • No oral or sublingual route offered yet
  • Newer operator (Gala GLP-1 by AI Coaching Inc) with a shorter public record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 34 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard